Balanced news tone
News Sentiment
4967 sentiment intelligence
Kobayashi Pharmaceutical Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
68/100 classification confidence.
directly relevant articles
high-authority source matches
-0.6% over one week, +1.3% over four weeks, trend inactive, and near fair-value range.
ETFs Investing in Kobayashi Pharmaceutical Co., Ltd. Stocks
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
ETFs Investing in Kobayashi Pharmaceutical Co., Ltd. Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 00:36
- Source
- TradingView
Kobayashi Pharmaceutical navigates safety review. Long-term strategy and consumer health focus stand
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 17:31
- Source
- ad-hoc-news.de
Enterprise value to revenue forward of Kobayashi Pharmaceutical Co., Ltd. – TSE:4967
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jul 2026 08:13
- Source
- TradingView
Kobayashi Pharmaceutical highlights its consumer health portfolio as investors eye long-term growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Jul 2026 16:20
- Source
- ad-hoc-news.de
Kobayashi Pharmaceutical Co stock (JP3301100008): After recall scandal, focus shifts to recovery and
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 08 Jun 2026 07:00
- Source
- ad-hoc-news.de